Related Experiment Video
Updated: Apr 7, 2026

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation
Published on: July 23, 2012
Critical role for syndecan-4 in dendritic cell migration during development of allergic airway inflammation
Tobias Polte1,2, Susanne Petzold1,2, Jessica Bertrand3
1Department of Environmental Immunology, UFZ-Helmholtz Centre for Environmental Research Leipzig-Halle, Permoserstrasse 15, Leipzig 04318, Germany.
Abstract:
Syndecan-4 (SDC4), expressed on dendritic cells (DCs) and activated T cells, plays a crucial role in DC motility and has been shown as a potential target for activated T-cell-driven diseases. In the present study, we investigate the role of SDC4 in the development of T-helper 2 cell-mediated allergic asthma. Using SDC4-deficient mice or an anti-SDC4 antibody we show that the absence or blocking of SDC4 signalling in ovalbumin-sensitized mice results in a reduced asthma phenotype compared with control animals. Most importantly, even established asthma is significantly decreased using the anti-SDC4 antibody. The disturbed SDC4 signalling leads to an impaired motility and directional migration of antigen-presenting DCs and therefore, to a modified sensitization leading to diminished airway inflammation. Our results demonstrate that SDC4 plays an important role in asthma induction and indicate SDC4 as possible target for therapeutic intervention in this disease.
Insights
Syndecan-4 (SDC4) is crucial for allergic asthma development by affecting dendritic cell migration. Blocking SDC4 signaling reduces asthma symptoms, even in established cases, indicating its therapeutic potential.
Area of Science:
- Immunology
- Cell Biology
Background:
- Syndecan-4 (SDC4) is expressed on dendritic cells (DCs) and activated T cells, influencing DC motility.
- SDC4 is a potential therapeutic target for T-cell-driven diseases.
Purpose of the Study:
- To investigate the role of SDC4 in the development of T-helper 2 cell-mediated allergic asthma.
- To evaluate SDC4 as a therapeutic target for established allergic asthma.
Main Methods:
- Utilized SDC4-deficient mice and an anti-SDC4 antibody in an ovalbumin-induced asthma model.
- Assessed asthma phenotype, DC motility, and airway inflammation.
Main Results:
- Absence or blockade of SDC4 signaling significantly reduced the asthma phenotype in ovalbumin-sensitized mice.
- Anti-SDC4 antibody treatment decreased established asthma symptoms.
- SDC4 signaling disruption impaired DC motility and directional migration, leading to reduced airway inflammation.
Conclusions:
- SDC4 plays a critical role in the induction of allergic asthma.
- Targeting SDC4 signaling offers a promising therapeutic strategy for asthma intervention.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cytoskeletal Coordination in Cell Migration
Intracellular Signaling Affects Focal Adhesions
Some...
Cell Migration

